![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cash position of €10.3 million as of June 30, 2024 Continuation of partnership discussions on M1Pram with Sanofi BioChaperone® Lispro Phase 3 study is on track for completion in December...
Regulatory News: Under the liquidity agreement entrusted by ADOCIA (Paris:ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on June 30th 2024 : Number...
Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers...
Tonghua Dongbao made this strategic decision after re-assessment of its R&D pipeline and considering the recent regulatory and competitive environment changes Adocia regains full rights on...
Des données précliniques exclusives ont été sélectionnées pour être présentées à l'ADA sur trois des programmes innovants d'Adocia : AdoShell®, dont l’objectif est de proposer un traitement...
Regulatory News: Conformément aux dispositions de l’article L.233-8 II du Code de Commerce et de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers (« AMF »). ADOCIA SA...
Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques...
Mathieu-William Gilbert, nouveau Directeur des Opérations d'Adocia, occupait préalablement des positions de Vice-Présidence et de Direction Générale au sein du laboratoire Novo Nordisk Dans son...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | -8.73 | -75.3886010363 | 11.58 | 11.96 | 2.5 | 30313 | 7.21852822 | CS |
52 | -8.47 | -74.8233215548 | 11.32 | 11.96 | 2.5 | 12121 | 8.51706174 | CS |
156 | -7.2 | -71.6417910448 | 10.05 | 11.96 | 2.5 | 12614 | 9.85734952 | CS |
260 | -7.12 | -71.4142427282 | 9.97 | 11.96 | 2.5 | 19932 | 9.9890508 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions